UB
MDGL icon

UMB Bank’s Madrigal Pharmaceuticals MDGL Stock Holding History

UMB Bank’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$124K Buy
231
+1
+0.4% +$512 ﹤0.01% 945
2026
Q1 		$120K Hold
230
– – ﹤0.01% 894
2025
Q4 		$134K Hold
230
– – ﹤0.01% 816
2025
Q3 		$105K Sell
230
-3
-1% -$1.12K ﹤0.01% 840
2025
Q2 		$70.5K Hold
233
– – ﹤0.01% 977
2025
Q1 		$77.2K Sell
233
-1
-0.4% -$329 ﹤0.01% 877
2024
Q4 		$72.2K Buy
234
+2
+0.9% +$563 ﹤0.01% 785
2024
Q3 		$49.2K Buy
232
+2
+0.9% +$512 ﹤0.01% 876
2024
Q2 		$64.4K Buy
230
+30
+15% +$7.14K ﹤0.01% 779
2024
Q1 		$53.4K Buy
+200
New +$47.1K ﹤0.01% 822

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UMB Bank's MDGL Position: Q2 2026 in Review

UMB Bank increased its Madrigal Pharmaceuticals (MDGL) stake by 0.43% in Q2 2026, buying an estimated $512 and bringing the position to 231 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #945.

UMB Bank first reported a position in MDGL in Q1 2024 and has held it in 10 quarters since. The position peaked at $134K in Q4 2025. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • UMB Bank held 231 shares of Madrigal Pharmaceuticals worth $124K as of Q2 2026.
  • UMB Bank bought 1 Madrigal Pharmaceuticals share in Q2 2026, an estimated $512.
  • Madrigal Pharmaceuticals made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #945 holding.
  • UMB Bank first reported a position in Madrigal Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • UMB Bank's Madrigal Pharmaceuticals position peaked at $134K in Q4 2025.
  • 413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.